226 related articles for article (PubMed ID: 8779095)
1. [Current approaches to the treatment of diffuse toxic goiter].
Balabolkin MI
Ter Arkh; 1995; 67(10):15-8. PubMed ID: 8779095
[No Abstract] [Full Text] [Related]
2. The management of hyperthyroidism. A surgeon's perspective.
Falk SA
Otolaryngol Clin North Am; 1990 Jun; 23(3):361-80. PubMed ID: 1694983
[TBL] [Abstract][Full Text] [Related]
3. [The diagnosis and treatment of diffuse toxic goiter (a lecture)].
Petunina NA; Balabolkin MI
Ter Arkh; 1997; 69(10):12-7. PubMed ID: 9471780
[No Abstract] [Full Text] [Related]
4. Treatment of Graves' hyperthyroidism: evidence-based and emerging modalities.
Hegedüs L
Endocrinol Metab Clin North Am; 2009 Jun; 38(2):355-71, ix. PubMed ID: 19328416
[TBL] [Abstract][Full Text] [Related]
5. [The treatment of hyperthyroidism with and indication for radioactive iodine].
Klokke AR; van der Vijver JC
Ned Tijdschr Geneeskd; 1995 Apr; 139(16):819-21. PubMed ID: 7537352
[No Abstract] [Full Text] [Related]
6. Remission of aplastic anemia induced by treatment for Graves disease in a pediatric patient.
Das PK; Wherrett D; Dror Y
Pediatr Blood Cancer; 2007 Aug; 49(2):210-2. PubMed ID: 16456859
[TBL] [Abstract][Full Text] [Related]
7. Hyperthyroidism.
Helling TJ
Lancet; 2003 Nov; 362(9395):1584-5. PubMed ID: 14615127
[No Abstract] [Full Text] [Related]
8. [Treatment with iodine radioisotopes and thyroid-associated ophthalmopathy in Graves' disease].
Rasmussen AK; Feldt-Rasmussen UF
Ugeskr Laeger; 1999 Oct; 161(43):5933-4. PubMed ID: 10778332
[No Abstract] [Full Text] [Related]
9. [Treatment of Basedow's disease].
Bürgi H
Rev Med Suisse Romande; 1975 May; 95(5):325-43. PubMed ID: 52173
[No Abstract] [Full Text] [Related]
10. [Treatment of thyrotoxicosis].
Guillausseau-Scholer C
Soins; 1990 Feb; (533):12-4. PubMed ID: 1690919
[No Abstract] [Full Text] [Related]
11. Thyrotoxicosis.
Franklyn J
Clin Med (Lond); 2003; 3(1):11-5. PubMed ID: 12617406
[No Abstract] [Full Text] [Related]
12. Effect of therapy on the serum thyroglobulin concentration in patients with toxic diffuse goiter, toxic nodular goiter and toxic adenoma.
Ericsson UB; Tegler L; Dymling JF; Thorell JI
J Endocrinol Invest; 1987 Aug; 10(4):351-7. PubMed ID: 2445808
[TBL] [Abstract][Full Text] [Related]
13. [The management of thyrotoxicosis: a schematic approach].
Papi G; Carapezzi C; Corsello SM
Minerva Endocrinol; 2002 Jun; 27(2):119-26. PubMed ID: 11961503
[TBL] [Abstract][Full Text] [Related]
14. [Current concepts in the treatment of Basedow's disease].
Jaffiol C; Baldet L
Sem Hop; 1975 Sep 10-20; 51(37-38):2265-7. PubMed ID: 56038
[No Abstract] [Full Text] [Related]
15. Differences and similarities in the treatment of diffuse goiter in Europe and the United States.
Wartofsky L; Glinoer D; Solomon B; Lagasse R
Exp Clin Endocrinol; 1991 May; 97(2-3):243-51. PubMed ID: 1717298
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of diffuse toxic goiter with radioactive iodine in combination with prolonged antithyroid therapy].
Khramtsova VIa; Potin VV; Shliakhtina LG
Probl Endokrinol (Mosk); 1977; 23(2):48-51. PubMed ID: 71726
[TBL] [Abstract][Full Text] [Related]
17. [The treatment of toxic multinodular goiter].
Fagel WJ; van der Vijver JC
Ned Tijdschr Geneeskd; 1987 Feb; 131(6):252-3. PubMed ID: 2436063
[No Abstract] [Full Text] [Related]
18. [Complex treatment of toxic goiter].
Kal'chenko II; Nechiporenko FP
Sov Med; 1973 Oct; 36(10):99-102. PubMed ID: 4133131
[No Abstract] [Full Text] [Related]
19. [Are anti-thyroid drugs and iodine preparations for surgical preparation in Basedow's disease still current today?].
Hermann M; Richter B; Roschal A
Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():951-6. PubMed ID: 1724204
[TBL] [Abstract][Full Text] [Related]
20. [On the residual thyroid tissue after thyroidectomy for diffuse goiter with thyrotoxicosis].
Angelescu E; Stoenescu D; Damian A; Taşcă C
Stud Cercet Endocrinol; 1973; 24(6):465-71. PubMed ID: 4129363
[No Abstract] [Full Text] [Related]
[Next] [New Search]
